著者
鶴谷 秀人 佐伯 敬 岸川 禮子
出版者
一般社団法人 日本呼吸ケア・リハビリテーション学会
雑誌
日本呼吸ケア・リハビリテーション学会誌 (ISSN:18817319)
巻号頁・発行日
vol.2, no.2, pp.91-94, 1993-04-20 (Released:2020-09-01)
参考文献数
4

慢性呼吸不全患者の管理を行っていくうえで,循環動態の管理や合併した循環器疾患の治療は重要であり,ときに難渋することがある.そこで実際に遭遇する頻度の高い病態として,呼吸不全とは別個に合併する虚血性心疾患,左心不全,および呼吸器疾患ゆえみられる右心不全,不整脈についてそれぞれの診断と対応について述べた.いずれの病態においても治療の原則は,現存する呼吸不全状態を可能な限り改善維持することが必要と考えられる.
著者
岩永 知秋 横田 欣児 岸川 禮子 池田 東吾 鶴谷 秀人 広瀬 隆士 西間 三馨
出版者
JAPANESE SOCIETY FOR TUBERCULOSIS
雑誌
結核 (ISSN:00229776)
巻号頁・発行日
vol.72, no.1, pp.9-13, 1997-01-15 (Released:2011-05-24)
参考文献数
10

A 53-year-old man with multidrug resistant tuberculosis (MDR-TB) had been persistently positive for acid-fast bacilli (AFB) both on sputum smear and also on culture with the Ogawa egg medium for 30 years since 1951. The case had been treated previously with isoniazid, rifampin, streptomycin, ethambutol, kanamycin, ethionamide, paraaminosalicylate and cycloserine; however, M. tuberculosis strains isolated from this patient acquired a high resistance to all of these agents. Then, a new regimen of chemotherapy, INH combined with ofloxacin (OFLX) and amoxicillin-clavulanic acid (AMPC/CVA), was applied to the case. He was successfully treated with this regimen, and a marked decrease in the amount of AFB on smear as well as on culture was observed during the course of chemotherapy. No adverse effects were seen meanwhile. These data suggest that it is worth while to try a regimen containing AMPC/CVA and OFLX in the treatment of MDR-TB.